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A major bottleneck in the manufacture of recombinant
therapeutic proteins is the time and effort needed for
the generation of stable, high-producing mammalian cell
lines. Conventional gene transfer methods for stable cell
line generation rely on random transgene integration,
resulting in unpredictable and highly variable levels of
expression of the transgene in individual clones [1,2]. As
ac o n s e q u e n c e ,al a r g en u m b e ro fs t a b l yt r a n s f e c t e d
cells must be analyzed to recover a few high-producing
clones. Recently, we described the use of a PiggyBac
(PB) transposon for the generation of high-producing
mammalian cell lines [3]. The PB dual vector system
consists of 1) a donor vector carrying an artificial trans-
poson with a mammalian expression cassette for the
recombinant transgene and puromycin selection marker
and 2) a helper vector driving transient expression of
the PB transposase (PBase). PB transposition mediates
stable transgene integration via a “cut and paste”
mechanism in which the PBase excises the artificial
transposon sequence from the plasmid and catalyzes its
insertion into the host cell genome. A main advantages
of the PB system over conventional passive integration
are an improved efficiency of transgene integration
resulting in a more integration events and more stable
clones. Furthermore, PB favors transgene integration
into actively transcribed regions of the host genome [4].
The PB transposon has a high cargo capacity of up to
14 Kb and transposition results in the stable genomic
integration of well-defined sequences, thus reducing the
probability of integration of truncated, non-functional
transgenes [5]. Finally, recent reports have demonstrated
the feasibility of using the PB system to obtain persistent
expression of multiple genes carried either on a single
or on distinct donor vectors [6].
We initially determined the efficiency of the PB sys-
tem in the generation of stable lines using suspension
adapted mammalian cells. CHO and HEK 293 cells were
co-transfected with an eGFP-bearing donor plasmid
along with the PB helper plasmid. The cells were then
grown in the absence of puromycin, and the percentage
of GFP-expressing cells in each culture was determined
by flow cytometry on a daily basis. By 21 days post-
transfection, the remaining GFP-positive cells were
assumed to be recombinant. Compared to conventional
transfection of plasmid DNA, PB transposition resulted
in an improvement in the efficiency of stable cell line
generation up to 20-fold for both CHO and HEK 293
cells (Figure 1A).
To further evaluate the PB system, CHO cells expres-
sing a tumour necrosis factor receptor:Fc fusion protein
(TNFR:Fc) were generated either by PB-transposition or
by conventional transfection. Clonal cell lines were
recovered following selection in 50 or 10 µg/mL puro-
mycin for two weeks. Recovered lines were grown in
suspension culture for 7 days in 24-well plates after
which the medium was analyzed by ELISA to determine
TNFR:Fc productivity. Transposition increased the fre-
quency of high-producing clones in the transfected
population (Figure 1B). To further characterized for the
level and stability of transgene expression the original
cell pools generated by PB transposition or conventional
transfection, as well as the top 4 producers from each
transfection were cultivated in the absence of selection
in serum-free suspension culture, over a period of 16 or
14 weeks, respectively. When compared to clones and
cell pools generated by conventional transfection, PB-
derived cell lines and cell pools produced up to 4-fold
more recombinant protein and had greater transgene
expression stability (Figure 1C)
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lines derived by PB transposition are efficiently gener-
ated and are more productive than cell lines generated
by conventional transfection methods. Therefore, the PB
system represents a valuable and practical alternative to
standard plasmid transfection to efficiently generate cell
clones with stable and enhanced transgene expression.
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Figure 1 A) Enhanced stable integration efficiency in CHO and HEK 293 cells by PB transposition. B) Productivity analysis of CHO clonal cell lines
sorted from cell pools generated by PB transposition (PB) or conventional transfection (TX). C) Analysis of the stability of TNFR:Fc expression over
time and transgene copy number, for cell pools [PB(50), PB(10), TX(50), and TX(10)] and clonal lines generated by PB transposition (PB50 and
PB10) or conventional transfection (TX50 and TX10).
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